BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Besnier M, Gasparino S, Vono R, Sangalli E, Facoetti A, Bollati V, Cantone L, Zaccagnini G, Maimone B, Fuschi P, Da Silva D, Schiavulli M, Aday S, Caputo M, Madeddu P, Emanueli C, Martelli F, Spinetti G. miR-210 Enhances the Therapeutic Potential of Bone-Marrow-Derived Circulating Proangiogenic Cells in the Setting of Limb Ischemia. Mol Ther 2018;26:1694-705. [PMID: 29908843 DOI: 10.1016/j.ymthe.2018.06.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Pu Y, Li C, Qi X, Xu R, Dong L, Jiang Y, Gong Q, Wang D, Cheng R, Zhang C, Chen Y. Extracellular Vesicles from NMN Preconditioned Mesenchymal Stem Cells Ameliorated Myocardial Infarction via miR-210-3p Promoted Angiogenesis. Stem Cell Rev Rep 2023. [PMID: 36696015 DOI: 10.1007/s12015-022-10499-6] [Reference Citation Analysis]
2 Tang H, Zhu W, Cao L, Zhang J, Li J, Ma D, Guo C. miR-210-3p protects against osteoarthritis through inhibiting subchondral angiogenesis by targeting the expression of TGFBR1 and ID4. Front Immunol 2022;13:982278. [DOI: 10.3389/fimmu.2022.982278] [Reference Citation Analysis]
3 Zhuang Y, Cheng M, Li M, Cui J, Huang J, Zhang C, Si J, Lin K, Yu H. Small extracellular vesicles derived from hypoxic mesenchymal stem cells promote vascularized bone regeneration through the miR-210-3p/EFNA3/PI3K pathway. Acta Biomater 2022:S1742-7061(22)00409-3. [PMID: 35850484 DOI: 10.1016/j.actbio.2022.07.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Han J, Luo L, Marcelina O, Kasim V, Wu S. Therapeutic angiogenesis-based strategy for peripheral artery disease. Theranostics 2022;12:5015-33. [PMID: 35836800 DOI: 10.7150/thno.74785] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Ring A, Ismaeel A, Wechsler M, Fletcher E, Papoutsi E, Miserlis D, Koutakis P. MicroRNAs in peripheral artery disease: potential biomarkers and pathophysiological mechanisms. Ther Adv Cardiovasc Dis 2022;16:17539447221096940. [PMID: 35583375 DOI: 10.1177/17539447221096940] [Reference Citation Analysis]
6 Deng M, Tong R, Zhang Z, Wang T, Liang C, Zhou X, Hou G. EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma. Cancer Cell Int 2021;21:535. [PMID: 34645436 DOI: 10.1186/s12935-021-02226-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Green CE, Clarke J, Bicknell R, Turner AM. Pulmonary MicroRNA Changes Alter Angiogenesis in Chronic Obstructive Pulmonary Disease and Lung Cancer. Biomedicines 2021;9:830. [PMID: 34356894 DOI: 10.3390/biomedicines9070830] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
8 Zaccagnini G, Greco S, Longo M, Maimone B, Voellenkle C, Fuschi P, Carrara M, Creo P, Maselli D, Tirone M, Mazzone M, Gaetano C, Spinetti G, Martelli F. Hypoxia-induced miR-210 modulates the inflammatory response and fibrosis upon acute ischemia. Cell Death Dis 2021;12:435. [PMID: 33934122 DOI: 10.1038/s41419-021-03713-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Gu Y, Rampin A, Alvino VV, Spinetti G, Madeddu P. Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy. Curr Diab Rep 2021;21:11. [PMID: 33651185 DOI: 10.1007/s11892-021-01378-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
10 Berndt R, Albrecht M, Rusch R. Strategies to Overcome the Barrier of Ischemic Microenvironment in Cell Therapy of Cardiovascular Disease. Int J Mol Sci 2021;22:2312. [PMID: 33669136 DOI: 10.3390/ijms22052312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Reddy LVK, Murugan D, Mullick M, Begum Moghal ET, Sen D. Recent Approaches for Angiogenesis in Search of Successful Tissue Engineering and Regeneration. Curr Stem Cell Res Ther 2020;15:111-34. [PMID: 31682212 DOI: 10.2174/1574888X14666191104151928] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
12 Xiang Y, Ma Y, Liu J, Wu Z, Wang X, Liu L, Wang G, Fu D, Shi W. Serotonin-induced miR-221/222 contribute to the activation of hepatic stellate cells. Biologia 2020;75:997-1007. [DOI: 10.2478/s11756-019-00376-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Li X, Jia Z, Zhao X, Xu M, Chen M. Expression of miR-210 in the peripheral blood of patients with newly diagnosed type 2 diabetes mellitus and its effect on the number and function of endothelial progenitor cells. Microvasc Res. 2020;131:104032. [PMID: 32533960 DOI: 10.1016/j.mvr.2020.104032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
14 Nazari-Shafti TZ, Exarchos V, Biefer HRC, Cesarovic N, Meyborg H, Falk V, Emmert MY. MicroRNA Mediated Cardioprotection - Is There a Path to Clinical Translation? Front Bioeng Biotechnol 2020;8:149. [PMID: 32266222 DOI: 10.3389/fbioe.2020.00149] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
15 Wang X, De Geyter C, Jia Z, Peng Y, Zhang H. HECTD1 regulates the expression of SNAIL: Implications for epithelial‑mesenchymal transition. Int J Oncol 2020;56:1186-98. [PMID: 32319576 DOI: 10.3892/ijo.2020.5002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
16 Zaccagnini G, Maimone B, Fuschi P, Longo M, Da Silva D, Carrara M, Voellenkle C, Perani L, Esposito A, Gaetano C, Martelli F. Hypoxia-Induced miR-210 Is Necessary for Vascular Regeneration upon Acute Limb Ischemia. Int J Mol Sci 2019;21:E129. [PMID: 31878120 DOI: 10.3390/ijms21010129] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
17 Amedei A, Morbidelli L. Circulating Metabolites Originating from Gut Microbiota Control Endothelial Cell Function. Molecules 2019;24:E3992. [PMID: 31694161 DOI: 10.3390/molecules24213992] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]
18 Sun B, Ding Y, Jin X, Xu S, Zhang H. Long non-coding RNA H19 promotes corneal neovascularization by targeting microRNA-29c. Biosci Rep 2019;39:BSR20182394. [PMID: 30948500 DOI: 10.1042/BSR20182394] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
19 Morbidelli L, Donnini S, Ziche M. Therapeutic Implications of the Nitric Oxide Pathway in the Angiogenesis of Tumors and Inflammatory-Related Disorders. Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders. Elsevier; 2019. pp. 65-91. [DOI: 10.1016/b978-0-12-816545-4.00004-9] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
20 Morbidelli L, Terzuoli E, Donnini S. Use of Nutraceuticals in Angiogenesis-Dependent Disorders. Molecules 2018;23:E2676. [PMID: 30340320 DOI: 10.3390/molecules23102676] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]